{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:24Z","timestamp":1791895584019,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67105-9","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T04:08:27Z","timestamp":1765166907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Widespread Fab-arm exchange affects all endogenous serum IgG4"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5256-594X","authenticated-orcid":false,"given":"Linus","family":"Wollenweber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-7903","authenticated-orcid":false,"given":"Albert","family":"Bondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-5042","authenticated-orcid":false,"given":"Maartje G.","family":"Huijbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-4404","authenticated-orcid":false,"given":"Albert J. R.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"67105_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 5, 520 (2014).","journal-title":"Front Immunol."},{"key":"67105_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1304365","volume":"14","author":"T Damelang","year":"2023","unstructured":"Damelang, T. et al. Impact of structural modifications of IgG antibodies on effector functions. Front Immunol. 14, 1304365 (2023).","journal-title":"Front Immunol."},{"key":"67105_CR3","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.4049\/jimmunol.159.7.3372","volume":"159","author":"KH Roux","year":"1997","unstructured":"Roux, K. H., Strelets, L. & Michaelsen, T. E. Flexibility of human IgG subclasses. J. Immunol. 159, 3372\u20133382 (1997).","journal-title":"J. Immunol."},{"key":"67105_CR4","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1021\/acscentsci.4c01157","volume":"10","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Human IgG subclasses differ in the structural elements of their N-glycosylation. ACS Cent. Sci. 10, 2048\u20132058 (2024).","journal-title":"ACS Cent. Sci."},{"key":"67105_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1074\/mcp.M114.047381","volume":"14","author":"R Plomp","year":"2015","unstructured":"Plomp, R. et al. Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3). Mol. Cell Proteom. 14, 1373\u20131384 (2015).","journal-title":"Mol. Cell Proteom."},{"key":"67105_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse, R. C., Stapel, S. O., Schuurman, J. & Rispens, T. Immunoglobulin G4: an odd antibody. Clin. Exp. Allergy 39, 469\u2013477 (2009).","journal-title":"Clin. Exp. Allergy"},{"key":"67105_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","volume":"105","author":"RC Aalberse","year":"2002","unstructured":"Aalberse, R. C. & Schuurman, J. IgG4 breaking the rules. Immunology 105, 9\u201319 (2002).","journal-title":"Immunology"},{"key":"67105_CR8","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1021\/ja203638y","volume":"133","author":"T Rispens","year":"2011","unstructured":"Rispens, T., Ooijevaar-de Heer, P., Bende, O. & Aalberse, R. C. Mechanism of immunoglobulin G4 Fab-arm exchange. J. Am. Chem. Soc. 133, 10302\u201310311 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"67105_CR9","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.4049\/jimmunol.137.11.3566","volume":"137","author":"JS van der Zee","year":"1986","unstructured":"van der Zee, J. S., van Swieten, P. & Aalberse, R. C. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J. Immunol. 137, 3566\u20133571 (1986).","journal-title":"J. Immunol."},{"key":"67105_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1046\/j.1365-2567.1999.00845.x","volume":"97","author":"J Schuurman","year":"1999","unstructured":"Schuurman, J. et al. Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites. Immunology 97, 693\u2013698 (1999).","journal-title":"Immunology"},{"key":"67105_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0161-5890(01)00050-5","volume":"38","author":"J Schuurman","year":"2001","unstructured":"Schuurman, J., Perdok, G. J., Gorter, A. D. & Aalberse, R. C. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol. Immunol. 38, 1\u20138 (2001).","journal-title":"Mol. Immunol."},{"key":"67105_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","volume":"317","author":"M van der Neut Kolfschoten","year":"2007","unstructured":"van der Neut Kolfschoten, M. et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317, 1554\u20131557 (2007).","journal-title":"Science"},{"key":"67105_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nbt.1553","volume":"27","author":"AF Labrijn","year":"2009","unstructured":"Labrijn, A. F. et al. Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo. Nat. Biotechnol. 27, 767\u2013771 (2009).","journal-title":"Nat. Biotechnol."},{"key":"67105_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.str.2011.06.016","volume":"19","author":"RebeccaJ Rose","year":"2011","unstructured":"Rose, R. ebeccaJ. et al. Quantitative Analysis of the Interaction Strength and Dynamics of Human IgG4 Half Molecules by Native Mass Spectrometry. Structure 19, 1274\u20131282 (2011).","journal-title":"Structure"},{"key":"67105_CR15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.4049\/jimmunol.1003336","volume":"187","author":"AF Labrijn","year":"2011","unstructured":"Labrijn, A. F. et al. Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength. J. Immunol. 187, 3238\u20133246 (2011).","journal-title":"J. Immunol."},{"key":"67105_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/imm.12265","volume":"142","author":"E Young","year":"2014","unstructured":"Young, E. et al. Estimation of polyclonal IgG4 hybrids in normal human serum. Immunology 142, 406\u2013413 (2014).","journal-title":"Immunology"},{"key":"67105_CR17","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","volume":"12","author":"G Kwok","year":"2016","unstructured":"Kwok, G., Yau, T. C., Chiu, J. W., Tse, E. & Kwong, Y. L. Pembrolizumab (Keytruda). Hum. Vaccin Immunother. 12, 2777\u20132789 (2016).","journal-title":"Hum. Vaccin Immunother."},{"key":"67105_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2178220","volume":"19","author":"CM Cicala","year":"2023","unstructured":"Cicala, C. M., Musacchio, L., Scambia, G. & Lorusso, D. Dostarlimab: From preclinical investigation to drug approval and future directions. Hum. Vaccin Immunother. 19, 2178220 (2023).","journal-title":"Hum. Vaccin Immunother."},{"key":"67105_CR19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/19420862.2019.1664365","volume":"11","author":"C Dumet","year":"2019","unstructured":"Dumet, C., Pottier, J., Gouilleux-Gruart, V. & Watier, H. Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development. mAbs 11, 1341\u20131350 (2019).","journal-title":"mAbs"},{"key":"67105_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","volume":"63","author":"F Meiler","year":"2008","unstructured":"Meiler, F., Klunker, S., Zimmermann, M., Akdis, C. A. & Akdis, M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 63, 1455\u20131463 (2008).","journal-title":"Allergy"},{"key":"67105_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ebiom.2019.11.006","volume":"50","author":"J Eckl-Dorna","year":"2019","unstructured":"Eckl-Dorna, J. et al. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response. EBioMedicine 50, 421\u2013432 (2019).","journal-title":"EBioMedicine"},{"key":"67105_CR22","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.4049\/jimmunol.150.9.3941","volume":"150","author":"A Kurniawan","year":"1993","unstructured":"Kurniawan, A. et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J. Immunol. 150, 3941\u20133950 (1993).","journal-title":"J. Immunol."},{"key":"67105_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.cels.2021.08.008","volume":"12","author":"A Bondt","year":"2021","unstructured":"Bondt, A. et al. Human plasma IgG1 repertoires are simple, unique, and dynamic. Cell Syst. 12, 1131\u20131143.e1135 (2021).","journal-title":"Cell Syst."},{"key":"67105_CR24","doi-asserted-by":"crossref","unstructured":"Bondt, A., Dingess, K. A., Hoek, M., van Rijswijck, D. M. H., Heck, A. J. R. A Direct MS-based approach to profile human milk secretory immunoglobulin A (IgA1) reveals donor-specific clonal repertoires with high longitudinal stability. Front. Immunol. 12 (2021).","DOI":"10.3389\/fimmu.2021.789748"},{"key":"67105_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1021\/acs.analchem.3c03712","volume":"96","author":"DMH van Rijswijck","year":"2024","unstructured":"van Rijswijck, D. M. H., Bondt, A., de Kat, N., Lood, R. & Heck, A. J. R. Direct comparison of the hinge-cleaving proteases IgdE and BdpK for LC-MS-based IgG1 clonal profiling. Anal. Chem. 96, 23\u201327 (2024).","journal-title":"Anal. Chem."},{"key":"67105_CR26","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3324\/haematol.2010.025783","volume":"95","author":"T van Meerten","year":"2010","unstructured":"van Meerten, T. et al. HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis. Haematologica 95, 2063\u20132071 (2010).","journal-title":"Haematologica"},{"key":"67105_CR27","doi-asserted-by":"publisher","first-page":"11886","DOI":"10.1039\/D0SC03438J","volume":"11","author":"MA den Boer","year":"2020","unstructured":"den Boer, M. A., Greisch, J. F., Tamara, S., Bondt, A. & Heck, A. J. R. Selectivity over coverage in de novo sequencing of IgGs. Chem. Sci. 11, 11886\u201311896 (2020).","journal-title":"Chem. Sci."},{"key":"67105_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47337-x","volume":"15","author":"EM Stork","year":"2024","unstructured":"Stork, E. M. et al. Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nat. Commun. 15, 3114 (2024).","journal-title":"Nat. Commun."},{"key":"67105_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1172\/JCI106279","volume":"49","author":"A Morell","year":"1970","unstructured":"Morell, A., Terry, W. D. & Waldmann, T. A. Metabolic properties of IgG subclasses in man. J. Clin. Invest 49, 673\u2013680 (1970).","journal-title":"J. Clin. Invest"},{"key":"67105_CR30","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","volume":"141","author":"E Blanco","year":"2018","unstructured":"Blanco, E. et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J. Allergy Clin. Immunol. 141, 2208\u20132219.e2216 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67105_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2191302","volume":"15","author":"P Cain","year":"2023","unstructured":"Cain, P., Huang, L., Tang, Y., Anguiano, V. & Feng, Y. Impact of IgG subclass on monoclonal antibody developability. MAbs 15, 2191302 (2023).","journal-title":"MAbs"},{"key":"67105_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg7327","volume":"8","author":"S Pillai","year":"2023","unstructured":"Pillai, S. Is it bad, is it good, or is IgG4 just misunderstood?. Sci. Immunol. 8, eadg7327 (2023).","journal-title":"Sci. Immunol."},{"key":"67105_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"T Rispens","year":"2023","unstructured":"Rispens, T. & Huijbers, M. G. The unique properties of IgG4 and its roles in health and disease. Nat. Rev. Immunol. 23, 763\u2013778 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"67105_CR34","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1126\/science.1148905","volume":"317","author":"DR Burton","year":"2007","unstructured":"Burton, D. R. & Wilson, I. A. Square-dancing antibodies. Science 317, 1507\u20131508 (2007).","journal-title":"Science"},{"key":"67105_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1073\/pnas.87.1.162","volume":"87","author":"LK Tan","year":"1990","unstructured":"Tan, L. K., Shopes, R. J., Oi, V. T. & Morrison, S. L. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc. Natl. Acad. Sci. USA 87, 162\u2013166 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67105_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/bj2810317","volume":"281","author":"DJ King","year":"1992","unstructured":"King, D. J. et al. Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab\u2019 fragment. Biochem. J. 281, 317\u2013323 (1992).","journal-title":"Biochem. J."},{"key":"67105_CR37","first-page":"1738","volume":"49","author":"D Colcher","year":"1989","unstructured":"Colcher, D. et al. Characterization and biodistribution of recombinant and recombinant\/chimeric constructs of monoclonal antibody B72.3. Cancer Res. 49, 1738\u20131745 (1989).","journal-title":"Cancer Res."},{"key":"67105_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pro.5560060217","volume":"6","author":"JW Bloom","year":"1997","unstructured":"Bloom, J. W., Madanat, M. S., Marriott, D., Wong, T. & Chan, S.-Y. Intrachain disulfide bond in the core hinge region of human IgG4. Protein Sci. 6, 407\u2013415 (1997).","journal-title":"Protein Sci."},{"key":"67105_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","volume":"77","author":"I Koneczny","year":"2017","unstructured":"Koneczny, I. et al. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. J. Autoimmun. 77, 104\u2013115 (2017).","journal-title":"J. Autoimmun."},{"key":"67105_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cbpa.2014.11.007","volume":"24","author":"JJ Lavinder","year":"2015","unstructured":"Lavinder, J. J., Horton, A. P., Georgiou, G. & Ippolito, G. C. Next-generation sequencing and protein mass spectrometry for the comprehensive analysis of human cellular and serum antibody repertoires. Curr. Opin. Chem. Biol. 24, 112\u2013120 (2015).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"67105_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3899\/jrheum.131017","volume":"41","author":"M Ahmad","year":"2014","unstructured":"Ahmad, M., Mahajan, V. S., Mattoo, H., Stone, J. H. & Pillai, S. Individuals with IgG4-related disease do not have an increased frequency of the K409 variant of IgG4 that compromises Fab-arm exchange. J. Rheumatol. 41, 185\u2013187 (2014).","journal-title":"J. Rheumatol."},{"key":"67105_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41435-021-00143-7","volume":"22","author":"I Khatri","year":"2021","unstructured":"Khatri, I. et al. Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations. Genes Immun. 22, 172\u2013186 (2021).","journal-title":"Genes Immun."},{"key":"67105_CR43","doi-asserted-by":"crossref","unstructured":"van Rijswijck, D.M. H. et al. Persistent IgG1 clones dominate and personalize the plasma antibody repertoire. Sci. Adv. (2025).","DOI":"10.1126\/sciadv.adt7746"},{"key":"67105_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade2798","volume":"8","author":"P Irrgang","year":"2023","unstructured":"Irrgang, P. et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci. Immunol. 8, eade2798 (2023).","journal-title":"Sci. Immunol."},{"key":"67105_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj9945","volume":"10","author":"N Lasrado","year":"2024","unstructured":"Lasrado, N. et al. Waning immunity and IgG4 responses following bivalent mRNA boosting. Sci. Adv. 10, eadj9945 (2024).","journal-title":"Sci. Adv."},{"key":"67105_CR46","doi-asserted-by":"crossref","unstructured":"Marchese, A. M. et al. Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines. J. Infect. 89 (2024).","DOI":"10.1016\/j.jinf.2024.106317"},{"key":"67105_CR47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers, M. G. et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur. J. Neurol. 22, 1151\u20131161 (2015).","journal-title":"Eur. J. Neurol."},{"key":"67105_CR48","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","volume":"73","author":"G Katz","year":"2022","unstructured":"Katz, G. & Stone, J. H. Clinical perspectives on IgG4-related disease and its classification. Annu Rev. Med 73, 545\u2013562 (2022).","journal-title":"Annu Rev. Med"},{"key":"67105_CR49","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa, T., Zen, Y., Pillai, S. & Stone, J. H. IgG4-related disease. Lancet 385, 1460\u20131471 (2015).","journal-title":"Lancet"},{"key":"67105_CR50","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","volume":"13","author":"A Bondt","year":"2014","unstructured":"Bondt, A. et al. Immunoglobulin G (IgG) FaB glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes*. Mol. Cell. Proteom. 13, 3029\u20133039 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"67105_CR51","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1073\/pnas.1220145110","volume":"110","author":"AF Labrijn","year":"2013","unstructured":"Labrijn, A. F. et al. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc. Natl. Acad. Sci. USA 110, 5145\u20135150 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67105_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"67105_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31492-0","volume":"13","author":"V Demichev","year":"2022","unstructured":"Demichev, V. et al. dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts. Nat. Commun. 13, 3944 (2022).","journal-title":"Nat. Commun."},{"key":"67105_CR54","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, Termed MaxLFQ*. Mol. Cell. Proteom. 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"67105_CR55","doi-asserted-by":"publisher","unstructured":"Wollenweber, L., Bondt, A., Vidarsson, G., Huijbers, M. G. & Heck, A. J. R. Widespread Fab-arm exchange affects all endogenous serum IgG4 Data and code. MassIVE repository. https:\/\/doi.org\/10.25345\/C5CC0V585 (2025).","DOI":"10.25345\/C5CC0V585"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67105-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:47Z","timestamp":1768341947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67105-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67105"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67105-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G.H. and G.V. are consultants for argenx. M.G.H. is a co-inventor on MuSK-related pending patents and LUMC and MGH receive royalties over these. LUMC receives royalties over a MuSK ELISA. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}